Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Zynaxis to develop Zyn-Linker form of paclitaxel for restenosis Rx

May 10, 1996

Cardioprotective activity of LU-51198 demonstrated in animal model

May 10, 1996

5-HT2 antagonists claimed by Toa Eiyo

May 10, 1996

Napp introduces novel diltiazem formulation in U.K.

May 10, 1996

New antihypertensive/diuretic isolated from natural source

May 10, 1996

PD-161721: A new tool for the study of ET receptors

May 10, 1996

LU-135252 improves pulmonary hypertension in rats

May 10, 1996

Endothelin antagonists reported by Bristol-Myers Squibb

May 10, 1996

Ciba-Geigy reveals renin inhibitors

May 10, 1996

P&U reports most potent K(ATP)-channel blocker yet discovered

May 10, 1996

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...